Literature DB >> 25390135

Perspective: we need a global solution.

Isaac Odame1.   

Abstract

Mesh：

Year:  2014        PMID： 25390135     DOI： 10.1038/515S10a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  A case for developing North-South partnerships for research in sickle cell disease.

Authors:  David Weatherall; Karen Hofman; Griffin Rodgers; John Ruffin; Sharon Hrynkow
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

Review 2.  A global perspective on sickle cell disease.

Authors:  Banu Aygun; Isaac Odame
Journal:  Pediatr Blood Cancer       Date:  2012-04-25       Impact factor: 3.167

3.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.

Authors:  Frédéric B Piel; Anand P Patil; Rosalind E Howes; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; William H Temperley; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Lancet       Date:  2012-10-25       Impact factor: 79.321
  3 in total
  11 in total

Review 1.  Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Authors:  Gregory M T Guilcher; Tony H Truong; Santosh L Saraf; Jacinth J Joseph; Damiano Rondelli; Matthew M Hsieh
Journal:  Semin Hematol       Date:  2018-04-25       Impact factor: 3.851

2.  Paper-based microchip electrophoresis for point-of-care hemoglobin testing.

Authors:  Muhammad Noman Hasan; Arwa Fraiwan; Ran An; Yunus Alapan; Ryan Ung; Asya Akkus; Julia Z Xu; Amy J Rezac; Nicholas J Kocmich; Melissa S Creary; Tolulope Oginni; Grace Mfon Olanipekun; Fatimah Hassan-Hanga; Binta W Jibir; Safiya Gambo; Anil K Verma; Praveen K Bharti; Suchada Riolueang; Takdanai Ngimhung; Thidarat Suksangpleng; Priyaleela Thota; Greg Werner; Rajasubramaniam Shanmugam; Aparup Das; Vip Viprakasit; Connie M Piccone; Jane A Little; Stephen K Obaro; Umut A Gurkan
Journal:  Analyst       Date:  2020-03-03       Impact factor: 4.616

Review 3.  Emerging point-of-care technologies for sickle cell disease screening and monitoring.

Authors:  Yunus Alapan; Arwa Fraiwan; Erdem Kucukal; M Noman Hasan; Ryan Ung; Myeongseop Kim; Isaac Odame; Jane A Little; Umut A Gurkan
Journal:  Expert Rev Med Devices       Date:  2016-11-22       Impact factor: 3.166

4.  Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease.

Authors:  Nagamani Vunnam; Scott Hansen; Dillon C Williams; MaryJane Olivia Been; Chih Hung Lo; Anil K Pandey; Carolyn N Paulson; John A Rohde; David D Thomas; Jonathan N Sachs; David K Wood
Journal:  Biomacromolecules       Date:  2022-08-09       Impact factor: 6.978

Review 5.  CRISPR/Cas9 gene editing for curing sickle cell disease.

Authors:  So Hyun Park; Gang Bao
Journal:  Transfus Apher Sci       Date:  2021-01-10       Impact factor: 1.764

6.  A Paper-Based Test for Screening Newborns for Sickle Cell Disease.

Authors:  Nathaniel Z Piety; Alex George; Sonia Serrano; Maria R Lanzi; Palka R Patel; Maria P Noli; Silvina Kahan; Damian Nirenberg; João F Camanda; Gladstone Airewele; Sergey S Shevkoplyas
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

7.  Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.

Authors:  So Hyun Park; Ciaran M Lee; Daniel P Dever; Timothy H Davis; Joab Camarena; Waracharee Srifa; Yankai Zhang; Alireza Paikari; Alicia K Chang; Matthew H Porteus; Vivien A Sheehan; Gang Bao
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

8.  Menstrual characteristics of sickle cell disease patients seen at a tertiary institution in North Western Nigeria.

Authors:  Amina Mohammed-Durosinlorun; Halima Bello-Manga; Joel Adze; Ifeoma P Ijei; Bature Stephen
Journal:  Ann Afr Med       Date:  2021 Oct-Dec

9.  Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.

Authors:  Esther O Oluwole; Titilope A Adeyemo; Gbemisola E Osanyin; Oluwakemi O Odukoya; Phyllis J Kanki; Bosede B Afolabi
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.752

10.  A retrospective case study of successful translational research: Gazelle Hb variant point-of-care diagnostic device for sickle cell disease.

Authors:  Kelli Qua; Shannon M Swiatkowski; Umut A Gurkan; Clara M Pelfrey
Journal:  J Clin Transl Sci       Date:  2021-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.